Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds Stephen J. Rulyak, MD, MPH, Michael B. Kimmey, MD, David L. Veenstra, PharmD, PhD, Teresa A. Brentnall, MD Gastrointestinal Endoscopy Volume 57, Issue 1, Pages 23-29 (January 2003) DOI: 10.1067/mge.2003.28 Copyright © 2003 American Society for Gastrointestinal Endoscopy Terms and Conditions
Fig. 1 Decision tree for endoscopic screening for pancreatic dysplasia among members of familial pancreatic cancer kindreds. Gastrointestinal Endoscopy 2003 57, 23-29DOI: (10.1067/mge.2003.28) Copyright © 2003 American Society for Gastrointestinal Endoscopy Terms and Conditions
Fig. 2 Two-way sensitivity analysis comparing the influence of prevalence of dysplasia and the sensitivity of EUS on the decision to proceed with screening. Screening becomes more effective as the prevalence of dysplasia and the sensitivity of EUS increase. The line depicts scenarios where the screening and no-screening options are equally effective. Gastrointestinal Endoscopy 2003 57, 23-29DOI: (10.1067/mge.2003.28) Copyright © 2003 American Society for Gastrointestinal Endoscopy Terms and Conditions